Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. FDA outlines path to test Alzheimer's drugs earlier
U.S. FDA outlines path to test Alzheimer's drugs earlier
U.S. FDA outlines path to test Alzheimer's drugs earlier
Submitted by
admin
on February 8, 2013 - 11:10am
Source:
Reuters
News Tags:
FDA
Alzheimer's disease
Eli Lilly
Pfizer
Elan
JNJ
Headline:
U.S. FDA outlines path to test Alzheimer's drugs earlier
Do Not Allow Advertisers to Use My Personal information
